924 results on '"Ilan, Yaron"'
Search Results
202. Extracts from Lentinula edodes (Shiitake) Edible Mushrooms Enriched with Vitamin D Exert an Anti-Inflammatory Hepatoprotective Effect
203. Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease
204. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
205. The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis
206. Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase
207. β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
208. The gut-kidney axis in chronic renal failure: A new potential target for therapy.
209. Tu2029 A novel method for anti-TNF based-oral immunotherapy: Oral administration of a plant cell-expressed recombinant anti-TNF fusion protein for treating of Crohn's disease
210. Mo1211 Oral Administration of Non-Absorbable Delayed Release 6-Mercaptopurine is Locally Active in the Gut, Exerts a Systemic Immune Effect and Alleviates Crohn's Disease With Low Rate of Side Effects: Results of Double Blind Phase II Clinical Trial
211. Immune therapy for hepatocellular carcinoma
212. Impaired liver regeneration by β‐glucosylceramide is associated with decreased fat accumulation
213. Immune Therapy for Nonalcoholic Steatohepatitis
214. Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells
215. Viral Diseases of the Liver.
216. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
217. Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C
218. Calcium and the Heart
219. Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients
220. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
221. S1860 The 13C Breath Test Identifies Decreased Beta-Oxidation and Improved Glucose Tolerance and Hepatic Impairment in Patients With Non Alcoholic Steatohepatitis After an Exercise and Diet Intervention
222. T1241 Promotion of CD4+CD25+FOXP3+ Regulatory Cells by Oral Administration of Locally Acting Delayed Release Low-Dose 6MP Formulation Alleviated Crohn's Disease: Results of Phase I/II Clinical Trial
223. Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease
224. Decreased STAT-1 phosphorylation by a thio analogue of beta-d-glucosylceramide is associated with altered NKT lymphocyte polarization
225. Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology
226. Oral tolerance: Can we make it work?
227. Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells
228. Evaluation of the 13C-Octanoate Breath Test as a Surrogate Marker of Liver Damage in Animal Models
229. 747 Decision Making in Clinical Hepatology Using the 13C Methacetin Breath Test: Results of a 614 Patient Clinical Trial
230. T1198 Oral Administration of Alequel™, a Mixture of Autologous Colon-Extracted Proteins for Treatment of Crohn's Disease: Results of a Double-Blind Clinical Trial
231. M1264 The Non-Invasive 13C Octanoate Breath Test Accurately Assesses Hepatic Mitochondrial Beta Oxidation Before and After Bariatric Surgery
232. S1837 The Point of Care 13C Methacetin Breath Test Accurately Predicts Long Term Prognosis in Patients with Chronic Liver Disease: A Non Invasive Liver Function Test
233. S1648 Type II Non Classical NKT Lymphocytes Are Crucial for Alleviation of TNBS Induced Immune Colitis: A Role for the Alteration of Membrane Lipid Rafts On Dendritic Cells
234. The Gut Mucosa as a Site for Induction of Regulatory T-Cells
235. β-Glycoglycosphingolipid-Induced Alterations of the STAT Signaling Pathways Are Dependent on CD1d and the Lipid Raft Protein Flotillin-2
236. Corrigendum
237. Erratum: Corrigendum: Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice
238. OR.104. Induction of Regulatory T Cells by Mucosal Administration of Aryl Hydrocarbon Receptor Ligands and Anti-CD3 Monoclonal Antibody in Animals and Humans
239. Point-of-care continuous13C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial
240. β-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat
241. Immune modulation by antibodies and antibody receptors
242. Utility of a13C-methacetin breath test in evaluating hepatic injury in rats
243. β-Glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping
244. NKT lymphocyte polarization determined by microenvironment signaling: A role for CD8+ lymphocytes and β-glycosphingolipids
245. Modulation of intracellular machinery by β-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis
246. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease
247. β-Glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: A novel adjuvant for HBV vaccination
248. 460 The 13c Methacetin Breath Test Accurately Identifies Liver Fibrosis in Patients with Chronic Hepatitis C Virus Infection: A Validation Study
249. β-Glycosphingolipids as Immune Modulators
250. Intrahepatic CD8+ lymphocyte trapping during tolerance induction using mushroom derived formulations: A possible role for liver in tolerance induction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.